Monitoring Brain Perfusion and Cerebral Oximetry in Carotid Endarterectomy Surgeries
NCT ID: NCT02102386
Last Updated: 2015-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
13 participants
OBSERVATIONAL
2014-02-28
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Procedures include:
Screening:
ECG, blood draw, neurological assessment, NIHSS
study: CerOX and TCD clock during CEA procedure, data collection from the medical record/monitors, neurological assessment, NIHSS
30 day follow-up
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cerebral Oximetry to Reduce Organ Dysfunction After Non-cardiac Surgery
NCT03861026
Study of Regional Cerebral Oxygenation and Brain Blood Volume Changes During Carotid Endarterectomy Using the NeurOS System
NCT03981757
Measuring and Treating Brain Oxygen Levels in Open Heart Surgery
NCT01539382
Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery
NCT01866657
Effects of Cerebral Oxygen Saturation on Neuropsychological Outcomes
NCT00151307
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CerOx
Patients will be monitored using the CerOx monitor. Probes will be attached bi-laterally in the OR to the forehead.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. National Institute of health Stroke Scale (NIHSS) score \>=10
3. Sub-cutaneous hematoma at the ipsilateral intended area of the CerOx probe location.
4. Laceration or scalp injury at the ipsilateral intended area of the CerOx probe location which contraindicates placement of the adhesive on the skin.
5. Patient with implants located in the intended area of the CerOx probe location.
6. Prisoners
7. Non-consenting patient Or non-participating surgeon schedule of assessments and procedures
8. Pregnant or lactating women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
kangrga
Clinical Chief Director, Abdominal Organ Transplant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ivan Kangrga, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Washington Univesity School of Medicine
Andrea Vannucci, MD
Role: PRINCIPAL_INVESTIGATOR
Washington University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Washington University School of Medicine
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201312041
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.